LanmanTAWuCCheungHGoyalNGreeneM. Guillain-Barré syndrome with rapid onset and autonomic dysfunction following first dose of Pfizer-BioNTech COVID-19 vaccine: A case report. Neurohospitalist. 2022;12:388-390. doi:10.1177/19418744211065242.
2.
GhazanfarHQaziRGhazanfarAIftekharS. Significance of brighton criteria in the early diagnosis and management of Guillain-Barré syndrome. Cureus. 2020;12:e8318. doi:10.7759/cureus.8318.
3.
PritchardJHughesRAHaddenRDBrassingtonR. Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndrome. Cochrane Database Syst Rev. 2016;11:CD008630. doi:10.1002/14651858.CD008630.pub4.
4.
OğuzISKayaZKirkizSKoçakÜ. Pulmonary embolism secondary to intravenous immunoglobulin in a child with leukemia. Turk J Haematol. 2021;38:335-336. doi:10.4274/tjh.galenos.2021.2021.0400.
5.
MadhavanAAGuerinJBEckelLJLehmanVTCarrCM. Dorsal cauda equina nerve root enhancement on magnetic resonance imaging due to ANNA-1-associated paraneoplastic polyneuropathy. Neuroradiol J. 2020;33:443-447. doi:10.1177/1971400920919689.
6.
FinstererJScorzaFAScorzaCA. Guillain-Barre syndrome related to SARS-CoV-2 vaccinations. Clinics. 2022. (in press).
